ILMN Illumina | $162.09 -0.5% | 6/1/2026 | | Boost Price Target | $170.00 ➝ $180.00 | Buy | 00.00% | View details for Guggenheim rating of Illumina (NASDAQ:ILMN) on 6/1/2026 |
OCS Oculis | $15.70 -30.8% | 6/1/2026 | | Lower Price Target | $75.00 ➝ $45.00 | Buy | 00.00% | View details for Guggenheim rating of Oculis (NASDAQ:OCS) on 6/1/2026 |
DLTR Dollar Tree | $115.90 -0.5% | 5/29/2026 | | Boost Price Target | $130.00 ➝ $135.00 | Buy | 00.00% | View details for Guggenheim rating of Dollar Tree (NASDAQ:DLTR) on 5/29/2026 |
BBY Best Buy | $75.78 -2.8% | 5/29/2026 | | Reiterated Rating | $90.00 | Buy | 00.00% | View details for Guggenheim rating of Best Buy (NYSE:BBY) on 5/29/2026 |
MDB MongoDB | $353.46 +5.3% | 5/29/2026 | | Reiterated Rating | $475.00 | Buy | 00.00% | View details for Guggenheim rating of MongoDB (NASDAQ:MDB) on 5/29/2026 |
GH Guardant Health | $127.36 -1.8% | 5/28/2026 | | Downgrade | | Buy | 00.00% | View details for Guggenheim rating of Guardant Health (NASDAQ:GH) on 5/28/2026 |
P Everpure | $81.53 +2.5% | 5/28/2026 | | Boost Price Target | $105.00 ➝ $115.00 | Buy | 00.00% | View details for Guggenheim rating of Everpure (NYSE:P) on 5/28/2026 |
ASMB Assembly Biosciences | $28.42 +2.7% | 5/28/2026 | | Reiterated Rating | $43.00 | Buy | 00.00% | View details for Guggenheim rating of Assembly Biosciences (NASDAQ:ASMB) on 5/28/2026 |
DY Dycom Industries | $504.59 -1.1% | 5/28/2026 | | Boost Price Target | $575.00 ➝ $620.00 | Buy | 00.00% | View details for Guggenheim rating of Dycom Industries (NYSE:DY) on 5/28/2026 |
JACK Jack In The Box | $12.66 +1.7% | 5/28/2026 | | Downgrade | | Buy ➝ Neutral | 00.00% | View details for Guggenheim rating of Jack In The Box (NASDAQ:JACK) on 5/28/2026 |
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
|
AZO AutoZone | $2,949.65 +0.5% | 5/27/2026 | | Lower Price Target | $4,400.00 ➝ $4,000.00 | Buy | 00.00% | View details for Guggenheim rating of AutoZone (NYSE:AZO) on 5/27/2026 |
PARR Par Pacific | $56.95 +1.4% | 5/27/2026 | | Upgrade | | Outperform | 00.00% | View details for Guggenheim rating of Par Pacific (NYSE:PARR) on 5/27/2026 |
PSX Phillips 66 | $177.87 +1.1% | 5/27/2026 | | Upgrade | | Outperform | 00.00% | View details for Guggenheim rating of Phillips 66 (NYSE:PSX) on 5/27/2026 |
CRWD CrowdStrike | $754.69 +3.2% | 5/27/2026 | | Reiterated Rating | | Neutral | 00.00% | View details for Guggenheim rating of CrowdStrike (NASDAQ:CRWD) on 5/27/2026 |
PANW Palo Alto Networks | $287.44 +2.0% | 5/27/2026 | | Downgrade | | Neutral ➝ Reduce | 00.00% | View details for Guggenheim rating of Palo Alto Networks (NASDAQ:PANW) on 5/27/2026 |
DAVA Endava | $3.25 +1.1% | 5/27/2026 | | Downgrade | | Buy ➝ Neutral | 00.00% | View details for Guggenheim rating of Endava (NYSE:DAVA) on 5/27/2026 |
ZS Zscaler | $149.35 +6.9% | 5/27/2026 | | Reiterated Rating | | Neutral | 00.00% | View details for Guggenheim rating of Zscaler (NASDAQ:ZS) on 5/27/2026 |
CRBP Corbus Pharmaceuticals | $7.88 -0.4% | 5/26/2026 | | Reiterated Rating | | Buy | 00.00% | View details for Guggenheim rating of Corbus Pharmaceuticals (NASDAQ:CRBP) on 5/26/2026 |
ROIV Roivant Sciences | $29.38 -2.0% | 5/26/2026 | | Boost Price Target | $30.00 ➝ $36.00 | Buy | 00.00% | View details for Guggenheim rating of Roivant Sciences (NASDAQ:ROIV) on 5/26/2026 |
QSR Restaurant Brands International | $74.55 -0.2% | 5/26/2026 | | Boost Price Target | $80.00 ➝ $85.00 | Buy | 00.00% | View details for Guggenheim rating of Restaurant Brands International (NYSE:QSR) on 5/26/2026 |
RLAY Relay Therapeutics | $13.78 -2.0% | 5/26/2026 | | Boost Price Target | $22.00 ➝ $26.00 | Buy | 00.00% | View details for Guggenheim rating of Relay Therapeutics (NASDAQ:RLAY) on 5/26/2026 |
IMVT Immunovant | $32.67 -1.9% | 5/26/2026 | | Boost Price Target | $44.00 ➝ $62.00 | Buy | 00.00% | View details for Guggenheim rating of Immunovant (NASDAQ:IMVT) on 5/26/2026 |
MWH SOLV Energy | $34.88 -1.8% | 5/26/2026 | | Boost Price Target | $37.00 ➝ $50.00 | Buy | 00.00% | View details for Guggenheim rating of SOLV Energy (NASDAQ:MWH) on 5/26/2026 |
AVLN Avalyn Pharma | $28.78
| 5/25/2026 | | Initiated Coverage | $80.00 | Buy | 00.00% | View details for Guggenheim rating of Avalyn Pharma (NASDAQ:AVLN) on 5/25/2026 |
AVLN Avalyn Pharma | $28.78
| 5/25/2026 | | Upgrade | | Strong-Buy | 00.00% | View details for Guggenheim rating of Avalyn Pharma (NASDAQ:AVLN) on 5/25/2026 |
SHLS Shoals Technologies Group | $12.20 -2.0% | 5/22/2026 | | Reiterated Rating | | Buy | 00.00% | View details for Guggenheim rating of Shoals Technologies Group (NASDAQ:SHLS) on 5/22/2026 |
AMRC Ameresco | $35.27 -2.0% | 5/22/2026 | | Initiated Coverage | | Neutral | 00.00% | View details for Guggenheim rating of Ameresco (NYSE:AMRC) on 5/22/2026 |
ETSY Etsy | $69.26 +2.0% | 5/21/2026 | | Initiated Coverage | | Buy | 00.00% | View details for Guggenheim rating of Etsy (NYSE:ETSY) on 5/21/2026 |
FSLR First Solar | $298.77 -2.6% | 5/21/2026 | | Boost Price Target | $269.00 ➝ $279.00 | Buy | 00.00% | View details for Guggenheim rating of First Solar (NASDAQ:FSLR) on 5/21/2026 |
OCS Oculis | $15.70 -30.8% | 5/20/2026 | | Initiated Coverage | $75.00 | Buy | 00.00% | View details for Guggenheim rating of Oculis (NASDAQ:OCS) on 5/20/2026 |
HD Home Depot | $311.01 -1.9% | 5/20/2026 | | Reiterated Rating | $425.00 | Buy | 00.00% | View details for Guggenheim rating of Home Depot (NYSE:HD) on 5/20/2026 |
TGT Target | $125.62 -1.1% | 5/20/2026 | | Reiterated Rating | $140.00 | Buy | 00.00% | View details for Guggenheim rating of Target (NYSE:TGT) on 5/20/2026 |
W Wayfair | $72.45 +0.3% | 5/20/2026 | | Reiterated Rating | $100.00 | Buy | 00.00% | View details for Guggenheim rating of Wayfair (NYSE:W) on 5/20/2026 |
EQIX Equinix | $1,053.49 -1.4% | 5/20/2026 | | Reiterated Rating | $1,235.00 | Buy | 00.00% | View details for Guggenheim rating of Equinix (NASDAQ:EQIX) on 5/20/2026 |
OCS Oculis | $15.70 -30.8% | 5/20/2026 | | Upgrade | | Strong-Buy | 00.00% | View details for Guggenheim rating of Oculis (NASDAQ:OCS) on 5/20/2026 |
STUB STUB | $9.89 +0.3% | 5/19/2026 | | Upgrade | $8.50 ➝ $12.50 | Neutral ➝ Buy | 00.00% | View details for Guggenheim rating of STUB (NYSE:STUB) on 5/19/2026 |
XE X-Energy | $26.60 -1.2% | 5/19/2026 | | Initiated Coverage | $57.00 | Buy | 00.00% | View details for Guggenheim rating of X-Energy (NASDAQ:XE) on 5/19/2026 |
ESTC Elastic | $63.97 -1.1% | 5/19/2026 | | Lower Price Target | $116.00 ➝ $106.00 | Buy | 00.00% | View details for Guggenheim rating of Elastic (NYSE:ESTC) on 5/19/2026 |
XE X-Energy | $26.60 -1.2% | 5/19/2026 | | Initiated Coverage | $57.00 | Buy | 00.00% | View details for Guggenheim rating of X-Energy (NASDAQ:XE) on 5/19/2026 |
TXRH Texas Roadhouse | $180.73 +0.1% | 5/18/2026 | | Reiterated Rating | $210.00 | Buy | 00.00% | View details for Guggenheim rating of Texas Roadhouse (NASDAQ:TXRH) on 5/18/2026 |
$30 stock to buy before Starlink goes public (WATCH NOW!) (Ad) A little-known stock pick with money-doubling potential over the next year is revealed for free in the first three minutes of a new video. This company is a critical piece of Elon Musk's fast-growing Starlink technology. It could climb 100 percent or more over the next year as Elon brings Starlink public in what may be the biggest IPO in history. No credit card is required to get the ticker. Watch the free video to get the ticker today. |
YSWY Yesway | $22.50
| 5/18/2026 | | Initiated Coverage | $30.00 | Buy | 00.00% | View details for Guggenheim rating of Yesway (NASDAQ:YSWY) on 5/18/2026 |
STUB STUB | $9.89 +0.3% | 5/15/2026 | | Boost Price Target | $7.50 ➝ $8.50 | Neutral | 00.00% | View details for Guggenheim rating of STUB (NYSE:STUB) on 5/15/2026 |
GTN Gray Media | $4.01 0.0% | 5/15/2026 | | Lower Price Target | $8.00 ➝ $7.00 | Buy | 00.00% | View details for Guggenheim rating of Gray Media (NYSE:GTN) on 5/15/2026 |
ALMS Alumis | $21.12 -2.2% | 5/15/2026 | | Boost Price Target | $32.00 ➝ $34.00 | Buy | 00.00% | View details for Guggenheim rating of Alumis (NASDAQ:ALMS) on 5/15/2026 |
MSGS Madison Square Garden | $376.24 +0.5% | 5/15/2026 | | Boost Price Target | $401.00 ➝ $422.00 | Buy | 00.00% | View details for Guggenheim rating of Madison Square Garden (NYSE:MSGS) on 5/15/2026 |
NFLX Netflix | $86.53 +0.6% | 5/15/2026 | | Reiterated Rating | $120.00 | Buy | 00.00% | View details for Guggenheim rating of Netflix (NASDAQ:NFLX) on 5/15/2026 |
UNCY Unicycive Therapeutics | $7.61 +3.1% | 5/13/2026 | | Reiterated Rating | $40.00 ➝ $37.00 | Buy | 00.00% | View details for Guggenheim rating of Unicycive Therapeutics (NASDAQ:UNCY) on 5/13/2026 |
BLLN Billiontoone | $96.84 -2.2% | 5/13/2026 | | Boost Price Target | $100.00 ➝ $120.00 | Buy | 00.00% | View details for Guggenheim rating of Billiontoone (NASDAQ:BLLN) on 5/13/2026 |
CRBP Corbus Pharmaceuticals | $7.88 -0.4% | 5/13/2026 | | Reiterated Rating | $45.00 | Buy | 00.00% | View details for Guggenheim rating of Corbus Pharmaceuticals (NASDAQ:CRBP) on 5/13/2026 |
DT Dynatrace | $43.31 +1.7% | 5/13/2026 | | Downgrade | | Buy ➝ Neutral | 00.00% | View details for Guggenheim rating of Dynatrace (NYSE:DT) on 5/13/2026 |
MTZ MasTec | $372.99 -1.4% | 5/13/2026 | | Upgrade | $480.00 | Neutral ➝ Buy | 00.00% | View details for Guggenheim rating of MasTec (NYSE:MTZ) on 5/13/2026 |
OLMA Olema Pharmaceuticals | $12.97 -1.7% | 5/13/2026 | | Lower Price Target | $38.00 ➝ $35.00 | Buy | 00.00% | View details for Guggenheim rating of Olema Pharmaceuticals (NASDAQ:OLMA) on 5/13/2026 |
ONON ON | $41.28 +1.1% | 5/13/2026 | | Reiterated Rating | $51.00 | Buy | 00.00% | View details for Guggenheim rating of ON (NYSE:ONON) on 5/13/2026 |
ELVN Enliven Therapeutics | $39.08 -1.3% | 5/12/2026 | | Initiated Coverage | $80.00 | Buy | 00.00% | View details for Guggenheim rating of Enliven Therapeutics (NASDAQ:ELVN) on 5/12/2026 |
DKNG DraftKings | $25.74 +5.1% | 5/11/2026 | | Lower Price Target | $37.00 ➝ $35.00 | Buy | 00.00% | View details for Guggenheim rating of DraftKings (NASDAQ:DKNG) on 5/11/2026 |
JBIO Jade Biosciences | $18.84 -10.5% | 5/11/2026 | | Boost Price Target | $23.00 ➝ $32.00 | Buy | 00.00% | View details for Guggenheim rating of Jade Biosciences (NASDAQ:JBIO) on 5/11/2026 |
CHRS Coherus Oncology | $1.62 +1.6% | 5/11/2026 | | Initiated Coverage | $12.00 | Buy | 00.00% | View details for Guggenheim rating of Coherus Oncology (NASDAQ:CHRS) on 5/11/2026 |
BCAX Bicara Therapeutics | $20.79 -4.4% | 5/11/2026 | | Initiated Coverage | $42.00 | Buy | 00.00% | View details for Guggenheim rating of Bicara Therapeutics (NASDAQ:BCAX) on 5/11/2026 |
CHRS Coherus Oncology | $1.62 +1.6% | 5/11/2026 | | Initiated Coverage | $12.00 | Buy | 00.00% | View details for Guggenheim rating of Coherus Oncology (NASDAQ:CHRS) on 5/11/2026 |
ELVN Enliven Therapeutics | $39.08 -1.3% | 5/11/2026 | | Upgrade | | Strong-Buy | 00.00% | View details for Guggenheim rating of Enliven Therapeutics (NASDAQ:ELVN) on 5/11/2026 |
SHAK Shake Shack | $64.09 -0.3% | 5/11/2026 | | Lower Price Target | $120.00 ➝ $100.00 | Buy | 00.00% | View details for Guggenheim rating of Shake Shack (NYSE:SHAK) on 5/11/2026 |
BCAX Bicara Therapeutics | $20.79 -4.4% | 5/10/2026 | | Upgrade | | Strong-Buy | 00.00% | View details for Guggenheim rating of Bicara Therapeutics (NASDAQ:BCAX) on 5/10/2026 |
ZVRA Zevra Therapeutics | $11.49 -0.9% | 5/8/2026 | | Boost Price Target | $23.00 ➝ $25.00 | Buy | 00.00% | View details for Guggenheim rating of Zevra Therapeutics (NASDAQ:ZVRA) on 5/8/2026 |
INSM Insmed | $105.16 -1.6% | 5/8/2026 | | Lower Price Target | $230.00 ➝ $226.00 | Buy | 00.00% | View details for Guggenheim rating of Insmed (NASDAQ:INSM) on 5/8/2026 |
WMG Warner Music Group | $31.71 +0.5% | 5/8/2026 | | Boost Price Target | $34.00 ➝ $36.00 | Buy | 00.00% | View details for Guggenheim rating of Warner Music Group (NASDAQ:WMG) on 5/8/2026 |
FROG JFrog | $81.70 +2.8% | 5/8/2026 | | Boost Price Target | $60.00 ➝ $80.00 | Buy | 00.00% | View details for Guggenheim rating of JFrog (NASDAQ:FROG) on 5/8/2026 |
AKAM Akamai Technologies | $150.59 +0.7% | 5/8/2026 | | Boost Price Target | $133.00 ➝ $181.00 | Buy | 00.00% | View details for Guggenheim rating of Akamai Technologies (NASDAQ:AKAM) on 5/8/2026 |
ARGX argenex | $829.61 -0.8% | 5/8/2026 | | Boost Price Target | $1,120.00 ➝ $1,135.00 | Buy | 00.00% | View details for Guggenheim rating of argenex (NASDAQ:ARGX) on 5/8/2026 |
ARHS Arhaus | $6.70 -1.0% | 5/8/2026 | | Lower Price Target | $14.00 ➝ $12.00 | Buy | 00.00% | View details for Guggenheim rating of Arhaus (NASDAQ:ARHS) on 5/8/2026 |
JANX Janux Therapeutics | $14.32 -1.9% | 5/8/2026 | | Lower Price Target | $68.00 ➝ $58.00 | Buy | 00.00% | View details for Guggenheim rating of Janux Therapeutics (NASDAQ:JANX) on 5/8/2026 |
PLNT Planet Fitness | $52.76 -1.4% | 5/8/2026 | | Lower Price Target | $126.00 ➝ $95.00 | Buy | 00.00% | View details for Guggenheim rating of Planet Fitness (NYSE:PLNT) on 5/8/2026 |
RARE Ultragenyx Pharmaceutical | $23.43 -2.2% | 5/8/2026 | | Lower Price Target | $52.00 ➝ $43.00 | Buy | 00.00% | View details for Guggenheim rating of Ultragenyx Pharmaceutical (NASDAQ:RARE) on 5/8/2026 |
TTD Trade Desk | $22.66 +5.1% | 5/8/2026 | | Lower Price Target | $28.00 ➝ $25.00 | Buy | 00.00% | View details for Guggenheim rating of Trade Desk (NASDAQ:TTD) on 5/8/2026 |
ENGN enGene | $1.83 -1.1% | 5/7/2026 | | Downgrade | | Buy ➝ Neutral | 00.00% | View details for Guggenheim rating of enGene (NASDAQ:ENGN) on 5/7/2026 |
DDOG Datadog | $256.77 +3.8% | 5/7/2026 | | Boost Price Target | $175.00 ➝ $225.00 | Buy | 00.00% | View details for Guggenheim rating of Datadog (NASDAQ:DDOG) on 5/7/2026 |
ONC BeOne Medicines | $283.46 -1.5% | 5/7/2026 | | Boost Price Target | $410.00 ➝ $420.00 | Buy | 00.00% | View details for Guggenheim rating of BeOne Medicines (NASDAQ:ONC) on 5/7/2026 |
RVMD Revolution Medicines | $155.24 -1.4% | 5/7/2026 | | Boost Price Target | $205.00 | Buy | 00.00% | View details for Guggenheim rating of Revolution Medicines (NASDAQ:RVMD) on 5/7/2026 |
PTLO Portillo's | $4.34 +1.0% | 5/7/2026 | | Downgrade | | Buy ➝ Neutral | 00.00% | View details for Guggenheim rating of Portillo’s (NASDAQ:PTLO) on 5/7/2026 |
ARM ARM | $409.67 +16.0% | 5/7/2026 | | Boost Price Target | $240.00 ➝ $255.00 | Buy | 00.00% | View details for Guggenheim rating of ARM (NASDAQ:ARM) on 5/7/2026 |
DIS Walt Disney | $100.88 -0.9% | 5/7/2026 | | Boost Price Target | $115.00 ➝ $120.00 | Buy | 00.00% | View details for Guggenheim rating of Walt Disney (NYSE:DIS) on 5/7/2026 |
NYT New York Times | $74.72 -0.7% | 5/7/2026 | | Boost Price Target | $63.00 ➝ $70.00 | Neutral | 00.00% | View details for Guggenheim rating of New York Times (NYSE:NYT) on 5/7/2026 |
WBD Warner Bros. Discovery | $27.05 +0.1% | 5/7/2026 | | Reiterated Rating | | Neutral | 00.00% | View details for Guggenheim rating of Warner Bros. Discovery (NASDAQ:WBD) on 5/7/2026 |
SPHR Sphere Entertainment | $139.68 +0.9% | 5/6/2026 | | Boost Price Target | $160.00 ➝ $175.00 | Buy | 00.00% | View details for Guggenheim rating of Sphere Entertainment (NYSE:SPHR) on 5/6/2026 |
LYV Live Nation Entertainment | $168.53 +0.1% | 5/6/2026 | | Boost Price Target | $192.00 ➝ $197.00 | Buy | 00.00% | View details for Guggenheim rating of Live Nation Entertainment (NYSE:LYV) on 5/6/2026 |
ADPT Adaptive Biotechnologies | $14.82 -2.2% | 5/6/2026 | | Reiterated Rating | $21.00 | Buy | 00.00% | View details for Guggenheim rating of Adaptive Biotechnologies (NASDAQ:ADPT) on 5/6/2026 |
NBIX Neurocrine Biosciences | $158.42 +0.1% | 5/6/2026 | | Reiterated Rating | $175.00 | Buy | 00.00% | View details for Guggenheim rating of Neurocrine Biosciences (NASDAQ:NBIX) on 5/6/2026 |
TWST Twist Bioscience | $65.96 -1.4% | 5/5/2026 | | Boost Price Target | $55.00 ➝ $60.00 | Buy | 00.00% | View details for Guggenheim rating of Twist Bioscience (NASDAQ:TWST) on 5/5/2026 |
CYRX CryoPort | $15.71 +0.1% | 5/5/2026 | | Boost Price Target | $11.00 ➝ $12.00 | Buy | 00.00% | View details for Guggenheim rating of CryoPort (NASDAQ:CYRX) on 5/5/2026 |
ACRS Aclaris Therapeutics | $4.51 -0.9% | 5/5/2026 | | Initiated Coverage | $12.00 | Buy | 00.00% | View details for Guggenheim rating of Aclaris Therapeutics (NASDAQ:ACRS) on 5/5/2026 |
LLY Eli Lilly and Company | $1,088.37 -1.5% | 5/5/2026 | | Reiterated Rating | $1,183.00 | Buy | 00.00% | View details for Guggenheim rating of Eli Lilly and Company (NYSE:LLY) on 5/5/2026 |
Your book attached (Ad) Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link.
He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing. Download the Safe Trade Options Formula book for free before access closes |
PINS Pinterest | $20.48 +2.2% | 5/5/2026 | | Boost Price Target | $21.00 ➝ $24.00 | Buy | 00.00% | View details for Guggenheim rating of Pinterest (NYSE:PINS) on 5/5/2026 |
PSKY Paramount Skydance | $10.61 0.0% | 5/5/2026 | | Lower Price Target | $14.00 ➝ $12.00 | Neutral | 00.00% | View details for Guggenheim rating of Paramount Skydance (NASDAQ:PSKY) on 5/5/2026 |
SBGI Sinclair | $14.06 +1.6% | 5/5/2026 | | Lower Price Target | $20.00 ➝ $19.00 | Buy | 00.00% | View details for Guggenheim rating of Sinclair (NASDAQ:SBGI) on 5/5/2026 |
WGS GeneDx | $50.89 -2.1% | 5/5/2026 | | Lower Price Target | $100.00 ➝ $70.00 | Buy | 00.00% | View details for Guggenheim rating of GeneDx (NASDAQ:WGS) on 5/5/2026 |
AXSM Axsome Therapeutics | $231.54 -1.3% | 5/4/2026 | | Boost Price Target | $245.00 ➝ $260.00 | Buy | 00.00% | View details for Guggenheim rating of Axsome Therapeutics (NASDAQ:AXSM) on 5/4/2026 |
ACHC Acadia Healthcare | $23.36 +0.7% | 5/4/2026 | | Boost Price Target | $26.00 ➝ $31.00 | Buy | 00.00% | View details for Guggenheim rating of Acadia Healthcare (NASDAQ:ACHC) on 5/4/2026 |
CELC Celcuity | $129.35 -2.7% | 5/4/2026 | | Boost Price Target | $135.00 ➝ $165.00 | Buy | 00.00% | View details for Guggenheim rating of Celcuity (NASDAQ:CELC) on 5/4/2026 |
ACRS Aclaris Therapeutics | $4.51 -0.9% | 5/4/2026 | | Upgrade | | Strong-Buy | 00.00% | View details for Guggenheim rating of Aclaris Therapeutics (NASDAQ:ACRS) on 5/4/2026 |
AMGN Amgen | $330.15 -2.0% | 5/4/2026 | | Lower Price Target | $351.00 ➝ $340.00 | Neutral | 00.00% | View details for Guggenheim rating of Amgen (NASDAQ:AMGN) on 5/4/2026 |
CI Cigna Group | $275.64 -0.6% | 5/4/2026 | | Boost Price Target | $334.00 ➝ $338.00 | Buy | 00.00% | View details for Guggenheim rating of Cigna Group (NYSE:CI) on 5/4/2026 |